Ushbu ish iqtibos qilgan ishlar

16 ta ish

Ish: A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

   Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

   Maqola20207 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006850

2. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   Maqola20196 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006848

3. Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

   Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25

   Maqola20226 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006859

4. Principles for designing future regimens for multidrug-resistant tuberculosis

   Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9

   Maqola20133 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006845

5. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Sharh maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006851

6. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

   Tadayuki Tanimura, Ernesto Jaramillo, Diana Weil +2

   Sharh maqola20142 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006844

7. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis

   Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006854

8. Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO

   Beverley Stringer, Karen Lowton, Nicola James +1

   Maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006857

9. Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial

   Bern-Thomas Nyang’wa, Frank Kloprogge, David Moore +4

   Maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006858

10. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006846

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006847

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006849

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006852

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006853

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006855

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006856